Ron Tsoumas
Analyst · Stifel. Go ahead, Matt
Thank you, Don, and good morning, everyone. Please turn to Slide 8. First quarter sales were 287.8 million in fiscal year '22 compared to 190.9 million in fiscal year '21, an increase of 96.9 million or 50.8%. The year-over-year quarterly comparisons include a favorable foreign currency impact on sales of 10.3 million in the current quarter. The increase was mainly due to lower sales in the prior year quarter from the impact of the COVID-19 pandemic and to higher sales of electric and hybrid electric vehicles, which amounted to 16% of sales in the first quarter of fiscal year '22, which was in line with our previous communication that electric vehicles and hybrid electric vehicle sales would comprise mid teens of our fiscal year '22 consolidated sales. In addition, stronger commercial vehicle sales contributed to the robust sales growth. First quarter net income increased 8.4 million to 29.1 million or $0.76 per share diluted from 20.7 million or $0.54 per diluted share in the same period last year. Net income benefited from increased sales and favorable currency translation, partially offset by higher income tax expense, higher costs from supply chain disruption, higher selling and administrative expenses, and lower other income. Please turn to Slide 9. First quarter gross margins were higher in fiscal year '22 as compared to fiscal year '21, mainly due to increased sales, partially offset by higher material costs, higher logistic costs, including freight and supply chain shortages. Fiscal year '22 first quarter margins were 24.9% as compared to 23.6% in the first quarter of fiscal year '21. That negative impact of the supply disruption and higher logistics costs, including freight, on the first quarter of fiscal year '22 gross margin was nearly 300 basis points. These higher costs that were experienced in the first quarter are expected to continue further in fiscal year '22. In addition, we anticipate a degree of cost inflation in the remainder of the current fiscal year. First quarter selling and administrative expenses as a percentage of sales decreased to 11.4% compared to 13.9% in the fiscal '21 first quarter. The fiscal year '22 first quarter percentage decrease was attributable to increase sales related to the negative impact of COVID-19 pandemic on fiscal '21 sales, partially offset by higher stock-based and performance-based compensation expenses. The first quarter of fiscal year '22 selling and administrative expenses percentage was in line with our historical norm, which should yield an efficient flow through from gross margin to operating income. Please turn to Slide 10. In addition to the gross margin and selling and administrative items mentioned above, two other non-operational items significantly impacted net income in the first quarter of fiscal year '22 as compared to the comparable quarter last fiscal year. First, income tax expense in the first quarter of fiscal year '22 was 5.7 million or 16.4% as compared to a net tax benefit of 5.1 million in the first quarter of fiscal year '21. The effective tax rate was lower in the first quarter of fiscal year '21 due to discrete tax benefits of 7.8 million in the quarter, or $0.20 per diluted share. Without the discrete tax benefits, the effective rate would have been 17.2%. The year-over-year tax expense increase was $10.8 million. Second, other income net was lower by 1.6 million mainly due to lower international government assistance between the comparable quarters. Shifting to EBITDA, a non-GAAP financial measure, fiscal year '22 first quarter EBITDA was 48.5 million versus 29.3 million in the same period last fiscal year. EBITDA was positively impacted by higher operating income, partially offset by lower other income. Please turn to Slide 11. Free cash flow, a non-GAAP financial measure, is defined as net cash provided from operating activities minus CapEx. For fiscal year '22 first quarter, free cash flow was a negative 6.2 million as compared to a positive 4.8 million in the first quarter of fiscal year '21. The decrease was mainly due to negative working capital changes, especially inventory, resulting from difficult logistics and higher capital expenditures. While we experienced negative free cash flow in the first quarter of fiscal year '22, we expect improvement the remainder of the fiscal year. We anticipate continuing our proven history of consistently generating reliable cash flows, which allow for ample funding of future organic growth, inorganic growth and return of capital to shareholders. In the first quarter of fiscal year '22, we invested approximately 15.9 million in CapEx as compared to 11.6 million in the first quarter of fiscal year '21. The higher first quarter CapEx is in line with our expectation that CapEx in fiscal year '22 would be higher than the investment in the prior year, estimated to be in the range of 53 million to 57 million. We have a strong balance sheet and we'll continue utilizing it by continuing investment in our businesses to grow them organically in the future. In addition, we continue to actively pursue opportunities for inorganic growth and have a measured return of capital to the shareholders. In the first quarter of fiscal year '22, we reduced gross debt by 4.7 million. Since our acquisition of Grakon in September 2018, we reduced gross debt by nearly 123 million. Regarding capital allocation, we recently announced two initiatives. First, on March 31, we announced a $100 million share repurchase program, which we execute as 7.6 million of repurchases during the first quarter of fiscal year '22. Since the authorization’s approval, we have purchased 15.1 million worth of shares at an average price of $46.45. In addition, we increased our quarterly dividend from $0.11 to $0.14 per quarterly share, an increase of 27%. We ended the first quarter with 207.9 million in cash. Please turn to Slide 12. As Don mentioned in his remarks, we have reaffirmed our previously issued guidance and earnings per share annual guidance. Guidance is based on management's best estimates. External events and their related potential impact on our financial results remain an ongoing challenge. While we have reaffirmed our guidance for the full year, persistent headwinds could cause our performance to be below the midpoint of the ranges as the situation is fluid and will likely remain very challenging. The revenue range for the full fiscal year '22 was between 1.175 billion to 1.235 billion. Diluted earnings per share ranges between $3.35 to $3.75 per share. The range is due to the uncertainty from the supply chain disruption for semiconductors and other materials on both Methode and its customers. From a sales perspective, lower sales could result from this slight disruption to us and/or our customers, which could result in lesser demand for our products for our ability to meet customer demand. Continuous supply chain disruption would also negatively impact gross margins due to additional costs incurred from premium freight, factory inefficiencies and to a lesser extent, tariffs and other logistic factors, including port congestion. Higher costs for materials, freight and labor are a constant and dynamic battle and we are uncertain as to when things will stabilize. Don, that concludes my comments.